Clorox stock hits 52-week low at $125.66 amid market challenges

Clorox (CLX) has hit a 52-week low of $125.66 amid market turbulence and concerns over supply chain issues and shifting consumer behavior, despite maintaining its dividend aristocrat status with a 3.83% yield. The decline follows a fiscal third-quarter earnings report that missed revenue and EPS expectations, with organic sales down 2% year-over-year, though gross margins improved to 44.6%; analysts are mixed on the stock, with Jefferies maintaining a Buy rating and a $167 price target, while Wells Fargo and JPMorgan revised their targets downward to $142 and $144, respectively, reflecting concerns about consumer demand and retailer destocking.

Analysis

Clorox Co. (NYSE:CLX) has reached a 52-week low of $125.66, reflecting a -5.65% stock price change over the past year amidst a turbulent market. The company is contending with significant headwinds, including supply chain disruptions and evolving post-pandemic consumer behavior. Despite these pressures, Clorox maintains its status as a dividend aristocrat, with 48 consecutive years of dividend increases and a current yield of 3.83%. InvestingPro analysis suggests the stock may be undervalued, with seven analysts recently revising earnings expectations upward. However, Clorox's fiscal third-quarter results missed expectations on both revenue and earnings per share (EPS), reporting an EPS of $1.45. Organic sales declined 2% year-over-year, contrary to projections of flat growth, attributed to slowing consumption and retailer inventory reductions. Positively, gross margin improved to 44.6%, exceeding expectations. The company's full-year 2025 EPS outlook remains unchanged, with an anticipated benefit from sales pull-forward. Analyst sentiment is mixed: Jefferies maintains a Buy rating with a $167 price target, while Wells Fargo revised its target to $142 (Equal Weight) and JPMorgan to $144 (Neutral), both citing concerns over consumer demand and retailer destocking. The appointment of Gina Boswell to the board expands its membership to 12, indicating ongoing strategic adjustments within the company as it navigates a complex economic landscape.

Key Decisions for Investors

• Investors should consider the stock's 52-week low and potential undervaluation signals against the backdrop of recent earnings misses and persistent operational challenges before initiating or adding to positions.
• Monitor upcoming earnings reports for evidence of stabilization in organic sales, improvements in retailer inventory dynamics, and sustained gross margin strength, as these will be key indicators of a potential recovery.
• Evaluate the mixed analyst outlook, with price targets ranging from $142 to $167, and weigh the attractive dividend yield against risks associated with consumer demand softness and retailer destocking when making investment decisions.